Salveo Specialty Pharmacy, Inc. Completes Additional Equity and Debt Financings and Acquisition of Mission Road Pharmacy

SAINT PETERSBURG, Fla., Dec. 4, 2012 /PRNewswire/ --Salveo Specialty Pharmacy, Inc., a specialty pharmacy company backed by Three Arch Partners, NewSpring Capital and Petra Capital Partners, today announces the completion of a second round of equity and debt funding, and its subsequent acquisition of Mission Road Pharmacy, a pharmacy based in Los Angeles, California focused on Oncology, HIV/AIDS, Hepatitis, Rheumatoid Arthritis and Mental Health therapies.

The additional equity financing was led by new investor, Sofinnova Ventures of Menlo Park, California. The debt financing included additional subordinated debt provided by Petra, as well as a new senior credit facility provided by Regions Bank. Garheng Kong, MD, PhD of Sofinnova will join the Salveo Board of Directors in conjunction with the investment.

Co-founded by Jeff Freedman (CEO) and Chuck Brown (COO), Salveo Specialty Pharmacy is a specialty pharmacy company focused on the acquisition and operation of selected specialty pharmacies throughout the United States. Focusing on chronic and often underserved disease states, the Company acquires pharmacies that share its commitment to improving chronic disease management and complement its existing operations, and then integrates them into a leading and unified specialty pharmacy organization. With the Mission Road Pharmacy acquisition, Salveo now has clinically-focused specialty pharmacy operations based in New York and Los Angeles, the two largest markets in the nation. Salveo will continue to focus on expanding its current customer base in these and new markets as well as integrating further acquisition targets. The former owners of Mission Road Pharmacy intend to remain with Salveo post-transaction.

Commented Garheng Kong, General Partner at Sofinnova Ventures, "We are excited to have partnered with the entire Salveo team to provide the Company with additional equity financing to support the Company's future growth. Salveo has assembled a strong management team and investor group experienced at growing young healthcare services companies. Sofinnova has successfully invested in specialty pharmaceutical products for many years, and Salveo represented a compelling opportunity for us to leverage that expertise to enter the rapidly-growing specialty pharmacy space.

Added Greg Ratliff, Senior Vice President with Regions' Healthcare Group, "We are very pleased about the opportunity to partner with Salveo and enhance its capital position as it continues to grow both organically and through acquisition. Regions has an extensive lending background within healthcare services and specialty pharmacy, and we look forward to providing debt capital to Salveo as it continues to execute on its strategic goals and initiatives."

The former principals of Mission commented, "We are thrilled to have found an ideal partner in Salveo. The Salveo team shares our same philosophy of always prioritizing superior patient care, customer service and clinical excellence. We are look forwarding to an excellent working relationship with the Salveo team and the continued growth of our business."

"The Salveo management team welcomes our new partners in Sofinnova Ventures and Regions Bank. Sofinnova brings to Salveo a wealth of experience in healthcare investing, providing capital and expertise to support the growth of emerging pharmaceutical and biotech companies. Additionally, Regions has a strong healthcare lending practice and a proven track record assisting growth-oriented companies like Salveo fund their expansion plans. With the continued support of Three Arch, NewSpring and Petra, and the addition of Sofinnova and Regions to the Salveo team, we have exciting plans to expand and extend our services to meet the complex needs of our patients and customers," said Jeff Freedman, CEO of Salveo. "And we look forward to working with the former owners of Mission and their entire team, who together have built an exceptional specialty pharmacy known for its clinical expertise, dedicated staff and their superior customer service and commitment to patient care."

About Salveo Specialty Pharmacy, Inc.

Salveo Specialty Pharmacy, Inc., a private company headquartered in Saint Petersburg, Florida, was formed to create a leading specialty pharmacy organization serving patients and customers across the country. Salveo acquires, integrates and grows select specialty pharmacy organizations that share its philosophy of providing superior customer service and clinical patient care to the chronically ill population. With this latest acquisition, Salveo further enhances its ability to deliver targeted and cost-effective therapy management services to an expanding base of chronic patients and their physicians, healthcare providers, and insurance plans.

About Three Arch Partners

See more here:
Salveo Specialty Pharmacy, Inc. Completes Additional Equity and Debt Financings and Acquisition of Mission Road Pharmacy